Healthcare RCM Contract Margin Finance VP — Interim

The mandate

The finance VP seat requires interim leadership while healthcare revenue-cycle contract margins are being forecast through revenue and staffing assumptions that do not consistently align. A service contract can grow while delivery effort, complexity and performance obligations erode contribution. The interim will hold the finance VP seat, restoring commercial-finance judgement without assuming patient-service, clinical or collection-practice authority.

The appointment runs twelve months from 19 October 2026, five working days weekly from Mumbai with scheduled overseas commercial-finance reviews. A permanent VP search continues during cover. The first contract review must identify the revenue basis, service complexity, capacity commitment and cost assumptions that genuinely determine margin, rather than accept revenue growth as evidence of improving economics.

Handover requires a contract contribution bridge, a capacity-linked forecast and business-finance owners able to explain changed delivery assumptions. The successor must lead a contract review and refresh a downside staffing scenario. Completing an automation project or hitting a predetermined margin is not the exit condition; dependable financial judgement and clear transfer of unresolved obligations are.

The VP may set commercial-finance evidence standards, allocate existing analyst work and approve planning recommendations inside the CFO's delegation. Contract changes, permanent staffing commitments and investments beyond delegated limits need executive approval. Services owners retain delivery decisions, and compliance owners retain interpretation of restricted healthcare processes; the interim cannot change those boundaries to produce a more favourable forecast.

Clinical operations, unrestricted billing-policy advice and a full service-platform replacement are excluded. The sponsor provides authorised contracts, capacity and cost records, with minimised operational information and nominated delivery owners. The role needs VP finance and enterprise planning scope that can join commercial judgement and delivery economics without claiming authority over healthcare matters outside finance.

What you will own

• Decide commercial-finance readiness for contract reviews, requiring evidence of revenue basis, service complexity and capacity commitment before margins inform executive action.
• Establish the contribution bridge with delivery and finance owners, separating price, volume, productivity and complexity effects so forecast deterioration has an explainable cause.
• Rebuild capacity-linked cash and margin scenarios that expose recruitment lead time, productive utilisation and collection delays, quantifying the unfunded staffing obligation before executives approve contract expansion.
• Set driver ownership for the planning cycle, preserving the original contract case and documenting why new delivery evidence changes the outlook.
• Reallocate existing analysts toward contract-complexity and utilisation uncertainties, recording deferred requests and assigning review dates so unresolved delivery-cost exposure remains visible in the commercial finance queue.
• Chair contract-finance decisions that preserve service and compliance approval boundaries, ensuring finance does not quietly assume authority over restricted healthcare practices.
• Transfer the commercial review pack and forecast method through live successor execution, confirming ownership of residual contract and capacity assumptions before exit.

Candidate qualifications

• Demonstrate VP finance or equivalent business-finance leadership in healthcare RCM, IT services or another complex delivery model. Explain a contract-margin decision you shaped and the capacity or complexity evidence that changed the original financial view.
• Show enterprise FP&A competence tied to service economics. Candidates should describe a staffing or productivity assumption tested, the source used and the cash consequence that could not be explained by revenue growth alone.
• Evidence commercial-finance judgement through pricing, scope and performance obligations. Provide a case where a growing contract weakened contribution and explain what finance could recommend versus what commercial or delivery executives had to approve.
• Demonstrate leadership across finance and service interfaces without claiming clinical or compliance authority. Explain an operating assumption escalated to the authorised specialist and how the unresolved condition remained visible in the forecast.
• Provide durable transfer proof and disciplined analytical capability. Show how another finance leader refreshed a contract scenario, preserved source ownership and challenged a new complexity assumption. Candidates should explain a forecast that remained conditional because reliable delivery evidence was missing, the interim financial decision still possible and why a central margin target could not replace that evidence.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 13 October 2026. Mandate reference PCT-INT-2026-IND-19.